761
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Role of microRNA-124-3p/Bax axis in neonatal hypoxic-ischaemic encephalopathy

, , &
Pages 163-170 | Received 29 Sep 2019, Accepted 29 Jan 2020, Published online: 11 Feb 2020

References

  • Lv H, Wang Q, Wu S, et al. Neonatal hypoxic ischemic encephalopathy-related biomarkers in serum and cerebrospinal fluid. Clin Chim Acta. 2015;450:282–297.
  • Silveira RC, Procianoy RS. Hypothermia therapy for newborns with hypoxic ischemic encephalopathy. J Pediatr. 2015;91(6):S78–S83.
  • Douglas-Escobar M, Weiss MD. Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr. 2015;169(4):397–403.
  • Vannucci RC, Connor JR, Mauger DT, et al. Rat model of perinatal hypoxic-ischemic brain damage. J Neurosci Res. 1999;55(2):158–163.
  • Perlman JM. Intervention strategies for neonatal hypoxic-ischemic cerebral injury. Clin Ther. 2006;28(9):1353–1365.
  • Li L, Klebe D, Doycheva D, et al. G-cSF ameliorates neuronal apoptosis through GSK-3β inhibition in neonatal hypoxia-ischemia in rats. Exp Neurol. 2015;263:141–149.
  • Mortezaei Z, Lanjanian H, Masoudi-Nejad A. Candidate novel long noncoding RNAs, microRNAs and putative drugs for Parkinson’s disease using a robust and efficient genome-wide association study. Genomics. 2017;109(3–4):158–164.
  • Li N, Pan X, Zhang J, et al. Plasma levels of mir-137 and mir-124 are associated with Parkinson’s disease but not with Parkinson’s disease with depression. Neurol Sci. 2017;38(5):761–767.
  • Ding X, Sun B, Huang J, et al. The role of miR-182 in regulating pineal CLOCK expression after hypoxia-ischemia brain injury in neonatal rats. Neurosci Lett. 2015;591:75–80.
  • Ma Q, Dasgupta C, Li Y, et al. Inhibition of microRNA-210 provides neuroprotection in hypoxic-ischemic brain injury in neonatal rats. Neurobiol Dis. 2016;89:202–212.
  • Wang L, Ke J, Li Y, et al. Inhibition of miRNA-210 reverses nicotine-induced brain hypoxic-ischemic injury in neonatal rats. Int J Biol Sci. 2017;13(1):76–84.
  • Xiong L, Zhou H, Zhao Q, et al. Overexpression of miR-124 protects against neurological dysfunction induced by neonatal hypoxic–ischemic brain injury. Cell Mol Neurobiol. 2020;1:1–14.
  • Cho KHT, Xu B, Blenkiron C, et al. Emerging roles of miRNAs in brain development and perinatal brain injury. Front Physiol. 2019;10:227.
  • Diana A, Gaido G, Murtas D. MicroRNA signature in human normal and tumoral neural stem cells. Int J Mol Sci. 2019;20(17):4123.
  • Lee MR, Kim JS, Kim KS. MiR-124a is important for migratory cell fate transition during gastrulation of human embryonic stem cells. Stem Cells. 2010;28(9):1550–1559.
  • Cheng LC, Pastrana E, Tavazoie M, et al. MiR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci. 2009;12(4):399–408.
  • Wang Y, Chen L, Wu Z, et al. MiR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL. BMC Cancer. 2016;16(1):826.
  • Zhang F, Wang B, Long H, et al. Decreased miR-124-3p expression prompted breast cancer cell progression mainly by targeting beclin-1. Clin Lab. 2016;62(6):1139–1145.
  • Zheng F, Liao YJ, Cai MY, et al. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut. 2012;61(2):278–289.
  • Kang Q, Xiang Y, Li D, et al. MiR-124-3p attenuates hyperphosphorylation of Tau protein-induced apoptosis via caveolin-1-PI3K/Akt/GSK3β pathway in N2a/APP695swe cells. Oncotarget. 2017;8(15):24314–24316.
  • Liu S, Qiu J, Tang X, et al. LncRNA-H19 regulates cell proliferation and invasion of ectopic endometrium by targeting ITGB3 via modulating miR-124-3p. Exp Cell Res. 2019;381(2):215–222.
  • Laferriere NR, Kurata WE, Grayson CT 3rd, et al. Inhibition of microRNA-124-3p as a novel therapeutic strategy for the treatment of Gulf War Illness: evaluation in a rat model. Neurotoxicology. 2019;71:16–30.
  • Rice J III, Vannucci R, Brierley JB. The influence of immaturity on hypoxic ischemic brain damage in the rat. Ann Neurol. 1981;9(2):131–141.
  • Birch D, Britt BC, Dukes SC, et al. MicroRNAs participate in the murine oligodendroglial response to perinatal hypoxia-ischemia. Pediatr Res. 2014;76(4):334–340.
  • Li Y, Zhang Z, Liu X, et al. MiR-124 functions as a tumor suppressor in the endometrial carcinoma cell line HEC-1B partly by suppressing STAT3. Mol Cell Biochem. 2014;388(1–2):219–231.
  • Dong P, Ihira K, Xiong Y, et al. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression. Oncotarget. 2016;7(15):20260–20270.
  • Huang S, Ge X, Yu J, et al. Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons. FASEB J. 2018;32(1):512–528.
  • Dong RF, Zhang B, Tai LW, et al. The neuroprotective role of MiR-124-3p in a 6-hydroxydopamine-induced cell model of Parkinson’s disease via the regulation of ANAX5. J Cell Biochem. 2018;119(1):269–277.
  • Shao Q, Jiang W, Jin Y. MiR-124 effect in neurons apoptosis in newborn rat with thyroid hypofunction. Int J Clin Exp Pathol. 2015;8(11):14465–14471.
  • Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74(4):609–619.
  • Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 1986;47(1):19–28.
  • Chen R, Wang M, Fu S, et al. MicroRNA-204 may participate in the pathogenesis of hypoxic-ischemic encephalopathy through targeting KLLN. Exp Ther Med. 2019;18(5):3299–3306.